Also known as FTS · Serum thymic factor · Facteur thymique sérique · Zinc-thymulin
A zinc-dependent thymic nonapeptide (serum thymic factor) that regulates T-cell differentiation.
Research refreshed
9 residues · single-letter amino-acid sequence
Thymulin is a thymic nonapeptide — historically called serum thymic factor (FTS, facteur thymique sérique) — that is biologically active only when bound to zinc. Secreted by thymic epithelial cells, it is involved in T-lymphocyte differentiation and immune regulation, and its activity falls with age and with zinc deficiency. It has been studied as an immunomodulatory and anti-inflammatory research peptide. It is not FDA-approved.
Thymulin is one of the classic thymic hormones, identified as the zinc-requiring serum thymic factor. Its defining feature is that the peptide itself is inactive until a zinc ion binds and locks it into the right shape — which ties its biological activity directly to zinc status, and is why aging and zinc deficiency, both of which lower active thymulin, are part of its research story.
It has been studied for its role in maturing T cells and, more recently, for anti-inflammatory and neuroimmune effects in animal models. It sits alongside the other thymic peptides in this catalog (thymalin, thymosin alpha-1, thymosin β4) as a tool for immune research. It is a research compound and is not FDA-approved; this page is a research and educational reference.
Zinc-dependent nonapeptide hormone of thymic epithelial origin; promotes T-cell differentiation and modulates cytokine signaling. The zinc ion is required to fold the peptide into its active conformation.
Behind every vial of Thymulin is the same exacting pipeline every research peptide runs — but the chemistry plays out differently for this molecule. Here is how Thymulin, specifically, is brought into being.
On paper, Thymulin weighs in at roughly 857.9 daltons. Before a single bond is made, the target sequence, salt form, and purity threshold are written down as the contract the finished material must meet.
Assembling Thymulin means roughly 9 coupling cycles on the synthesizer — one protected residue added at a time, which is also 9 chances for an incomplete coupling to seed a deletion impurity. It is a short sequence, which makes the build comparatively tractable — but short does not mean trivial, and purity is still won or lost downstream. It also carries cyclization, an extra step beyond a plain chain that adds both capability and cost.
The crude mixture — Thymulin plus its deletions and side products — is then separated on preparative HPLC, and where the cut is taken decides the difference between a genuinely pure peptide and a barely-passable one.
A real batch of Thymulin proves itself: identity confirmed by mass spectrometry against its ~857.9 Da, purity read directly off an analytical HPLC trace, water and counterion content measured. That batch-specific certificate of analysis is the only honest way to know what is actually in a vial of Thymulin — and a short, cold, accountable chain of custody is how that purity survives the trip to your bench.
A nonapeptide with an N-terminal pyroglutamate (a cyclized glutamine), made by solid-phase synthesis. The subtlety is that thymulin’s activity depends on coordinating a zinc ion, not on covalent structure alone — so a certificate of analysis for the peptide confirms the sequence and purity but not whether the active zinc-bound form is present. Pyroglutamate formation at the N-terminus is the notable synthetic detail.
Don't judge a vial by its cake. A fluffy, good-looking lyophilized powder reflects bulking agents and freeze-drying parameters — not purity. Insist on a batch-specific certificate of analysis.
Recent clinical trials and publications mentioning Thymulin, pulled automatically from ClinicalTrials.gov and PubMed and refreshed daily. Listings are unfiltered search results, not curated endorsements.
A zinc-dependent thymic nonapeptide (serum thymic factor) secreted by thymic epithelial cells that regulates T-cell differentiation and immune function.
Thymulin is only active when bound to zinc, which folds it into its functional shape — so its activity tracks zinc status and falls in zinc deficiency.
It is one of several thymic immune peptides in this catalog, alongside thymalin, thymosin alpha-1, and thymosin β4, each studied as an immune-research tool.
No — it is a research peptide, not FDA-approved. This page is a research and educational reference.
A 43-residue actin buffer. It holds G-actin so cells can move, and its first four residues become the anti-fibrotic peptide Ac-SDKP.
ViewThymus-derived polypeptide complex — the founding tissue bioregulator (Cytomax) studied for immune restoration.
ViewA synthetic thymic dipeptide (Glu-Trp) immunomodulator — the minimal active fragment distilled from thymus peptides.
ViewDosing protocols, mechanism, comparisons, and the latest trials — citation-backed answers grounded in PubMed, PubChem, and ClinicalTrials.gov.